BlackRock Health Sciences Term Trust (NYSE:BMEZ) Declares Monthly Dividend of $0.18

BlackRock Health Sciences Term Trust (NYSE:BMEZ) declared a monthly dividend on Friday, November 1st,NASDAQ Dividends reports. Shareholders of record on Friday, November 15th will be given a dividend of 0.1769 per share on Friday, November 29th. This represents a $2.12 dividend on an annualized basis and a yield of 13.54%. The ex-dividend date of this dividend is Friday, November 15th.

BlackRock Health Sciences Term Trust has increased its dividend payment by an average of 20.7% per year over the last three years.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BlackRock Health Sciences Term Trust stock traded down 0.05 during trading on Thursday, reaching 15.68. The stock had a trading volume of 33,165 shares, compared to its average volume of 263,622. The stock has a fifty day moving average price of 15.79 and a two-hundred day moving average price of 15.56. BlackRock Health Sciences Term Trust has a 52 week low of 13.53 and a 52 week high of 16.59.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. purchased 29,795 shares of the firm’s stock in a transaction dated Wednesday, October 16th. The stock was bought at an average cost of 15.81 per share, with a total value of 471,058.95. Following the purchase, the insider now directly owns 20,750,913 shares of the company’s stock, valued at 328,071,934.53. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. In the last quarter, insiders have bought 99,630 shares of company stock worth $1,585,113.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.